Peak6 Investments LLC Halozyme Therapeutics, Inc. Transaction History

Peak6 Investments LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$30.28 - $38.74 $8,054 - $10,304	266 New	266 $9,000
Q3 2019 Nov 08, 2019	SELL	$15.2 - $17.69 $410 - $477	-27 Reduced 2.88%	912 $14,000
Q2 2019 Aug 14, 2019	SELL	$14.75 - $17.26 $2,610 - $3,055	-177 Reduced 15.86%	939 $16,000
Q1 2019 May 15, 2019	SELL	$13.94 - $17.58 $6,203 - $7,823	-445 Reduced 28.51%	1,116 $18,000
Q4 2018 Feb 13, 2019	BUY	$13.33 - $18.66 $7,611 - $10,654	571 Added 57.68%	1,561 $23,000
Q3 2018 Nov 13, 2018	BUY	$16.68 - $18.41 $16,513 - $18,225	990 New	990 $18,000

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.